Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in medications originally developed for type 2 diabetes, has emerged as a powerful tool for weight management in adults with obesity or overweight conditions. The medication works by activating GLP-1 receptors in the brain to reduce hunger signals and increase feelings of fullness. Understanding how semaglutide dosing works—and how it's personalized to your individual needs—is essential for getting the most out of treatment.

How Semaglutide Dosing Works for Weight Loss

Semaglutide for weight loss follows a structured dose escalation schedule designed to minimize side effects while allowing your body to adapt. Treatment typically begins with a 0.25 mg injection once weekly, with increases occurring every 4 weeks until reaching a maintenance dose between 2.0 and 2.4 mg weekly. This gradual titration gives your gastrointestinal system time to acclimate, reducing nausea and improving overall tolerability.

The 16-week titration phase is standard across most treatment protocols, though individual timelines may vary based on tolerance and clinical response. Each dose increase represents a measured step forward, allowing your prescriber to assess how your body responds before moving to the next level. PlexusDx works with licensed 503A compounding pharmacies to ensure each injection contains the exact dose your treatment plan calls for, with accuracy verified at every step.

Starting Dose and Titration Schedule Explained

Your treatment journey begins at 0.25 mg once per week, the lowest effective starting dose for weight loss. Weeks 1 through 4 use this initial dose to allow your body to recognize and respond to GLP-1 activation. By week 5, the dose increases to 0.5 mg weekly, continuing this pattern of gradual escalation every 4 weeks until reaching your target maintenance dose.

Common maintenance doses include 1.7 mg, 2.0 mg, or 2.4 mg weekly, depending on your clinical response and tolerance profile. Some patients experience significant weight loss benefits at lower maintenance doses, while others require higher levels for optimal results. Your PlexusDx prescriber monitors your progress and adjusts your dose based on real-world outcomes, not a one-size-fits-all protocol.

Semaglutide Dose and Weight Loss Outcomes

Clinical trials demonstrate dose-dependent weight loss with semaglutide, with higher doses generally producing greater reductions in body weight. Patients on 2.4 mg weekly achieved average weight loss of approximately 15% of their starting body weight over 68 weeks in major research studies. Lower doses, such as 1.0 mg or 1.7 mg, still produce meaningful weight loss—often 10% to 12% of body weight—making them effective for patients who cannot tolerate or do not require the highest doses.

The relationship between dose and weight loss is not linear; the benefit per milligram decreases as doses increase, which is why personalized dosing is crucial. PlexusDx's approach recognizes that your optimal dose depends on your genetics, metabolism, medical history, and weight loss goals. The Precision Peptide Genetic Test identifies variants in genes like GLP1R and FTO that predict your individual response to semaglutide, helping your prescriber select the most effective dose from the start.

Maintaining Your Semaglutide Dose: Long-Term Therapy

Once you reach your target maintenance dose, you continue the same injection weekly to sustain weight loss and prevent weight regain. Long-term treatment with semaglutide maintains metabolic benefits and prevents the rapid weight rebound that often follows other weight loss interventions. Discontinuing semaglutide typically results in gradual weight regain over several months, which is why ongoing treatment is considered part of comprehensive weight management.

PlexusDx offers compounded semaglutide injections at a flat monthly price regardless of which maintenance dose you're using—your dose may increase, but your price remains the same. This transparent pricing model eliminates surprise costs as your treatment progresses. Patients can remain on their maintenance dose for as long as clinically appropriate, with regular follow-up visits and labs to confirm ongoing safety and efficacy.

Personalized Dosing: Beyond Standard Protocols

Standard semaglutide dosing provides a general framework, but your individual response depends on unique genetic and metabolic factors. Some patients experience excellent results at 1.0 mg weekly, while others require 2.4 mg to achieve their weight loss targets. Genetic variation in GLP-1 receptor sensitivity, insulin secretion pathways, and appetite regulation all influence how your body metabolizes semaglutide and responds to its effects.

PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides involved in weight regulation, including key variants like GLP1R rs6923761 and MC4R rs17782313. These genetic insights allow your PlexusDx prescriber to anticipate your likely response to semaglutide and make more informed dosing decisions earlier in treatment. The $99 test, available as an add-on after your first month of therapy, provides actionable data that improves treatment outcomes and reduces the trial-and-error phase of finding your optimal dose.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical starting dose of semaglutide for weight loss?

Semaglutide treatment begins at 0.25 mg injected once per week for the first 4 weeks. This low starting dose allows your gastrointestinal system to adapt gradually, reducing nausea and other early side effects. Your dose increases by 0.25 mg every 4 weeks until reaching your maintenance target, which typically ranges from 1.7 mg to 2.4 mg weekly.

How much weight can I lose on semaglutide, and does higher dose mean more weight loss?

Average weight loss ranges from 10% to 15% of starting body weight, with higher doses generally producing greater results. Patients on 2.4 mg weekly lose approximately 15% of body weight, while those on 1.0 to 1.7 mg average 10% to 12% loss. However, individual response varies based on genetics, lifestyle, and metabolic factors—some patients achieve excellent results at lower doses with fewer side effects.

Does my price increase when my semaglutide dose increases?

No. PlexusDx charges a flat monthly rate of $149 to $189 for compounded semaglutide injections regardless of your dose level. Your dose may need to go up during the titration phase, but your price won't. This transparent pricing removes financial uncertainty as your treatment progresses.

What happens if I stop taking semaglutide?

Weight regain typically begins within weeks of stopping semaglutide, with most patients returning to near their pre-treatment weight within several months. Semaglutide controls hunger and metabolism only while actively present in your system; discontinuing treatment removes this metabolic advantage. Long-term treatment is generally recommended to maintain weight loss and prevent relapse.

Can the Precision Peptide Genetic Test help determine my ideal semaglutide dose?

Yes. PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month) examines genetic variants in the GLP-1 receptor gene and related metabolic pathways that predict your individual response to semaglutide. Patients carrying certain variants at GLP1R rs6923761 or MC4R rs17782313 may require different dosing strategies for optimal results. This genetic data helps your prescriber personalize your dose from the start rather than relying solely on standard protocols.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves